Trexquant Investment LP

Position in URGN — UroGen Pharma Ltd.

CIK 1633445 STAMFORD, CT

Position in URGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,328,811

-$994,087 QoQ

Shares Held

73,905

-36.5% QoQ

Ownership

0.152%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $496,284,956 across 119 Biotechnology names. URGN ranks #78 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,328,811	73,905	-36.5%	Shares	Sole	2026-05-15
2025-09-30	$2,322,898	116,436	+653.4%	Shares	Sole	2025-11-14
2025-03-31	$170,921	15,454	-91.0%	Shares	Sole	2025-05-14
2024-12-31	$1,837,668	172,551	-36.5%	Shares	Sole	2025-02-12
2024-09-30	$3,450,209	271,670	+236.6%	Shares	Sole	2024-11-12
2024-06-30	$1,354,297	80,709	+446.7%	Shares	Sole	2024-08-13
2023-06-30	$152,797	14,763	-51.4%	Shares	Sole	2023-08-11
2022-06-30	$249,033	30,407	+67.1%	Shares	Sole	2022-08-11
2022-03-31	$158,487	18,196	+15.1%	Shares	Sole	2022-05-13
2020-12-31	$284,932	15,812	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.